Prostaglandin I2 Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension

dc.contributor.authorNorlander, Allison E.
dc.contributor.authorAbney, Masako
dc.contributor.authorCephus, Jacqueline-Yvonne
dc.contributor.authorRoe, Caroline E.
dc.contributor.authorIrish, Jonathan M.
dc.contributor.authorShelburne, Nicholas J.
dc.contributor.authorNewcomb, Dawn C.
dc.contributor.authorHemnes, Anna R.
dc.contributor.authorPeebles, R. Stokes, Jr.
dc.contributor.departmentAnatomy, Cell Biology and Physiology, School of Medicine
dc.date.accessioned2024-10-29T11:29:06Z
dc.date.available2024-10-29T11:29:06Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationNorlander AE, Abney M, Cephus JY, et al. Prostaglandin I2 Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2023;208(6):737-739. doi:10.1164/rccm.202304-0716LE
dc.identifier.urihttps://hdl.handle.net/1805/44309
dc.language.isoen_US
dc.publisherAmerican Thoracic Society
dc.relation.isversionof10.1164/rccm.202304-0716LE
dc.relation.journalAmerican Journal of Respiratory and Critical Care Medicine
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectEpoprostenol
dc.subjectFamilial primary pulmonary hypertension
dc.subjectPulmonary arterial hypertension
dc.titleProstaglandin I2 Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension
dc.typeArticle
ul.alternative.fulltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC10515570/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Norlander2023Prostaglandin-PP.pdf
Size:
629.36 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: